Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Prostaglandins don't genetically contribute to hair loss.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

A new gene, mrp4, is found in mice and may play a unique role in hair follicle development in tails and ears.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Progesterone protects rat brain cells by enhancing GABA A receptor activity.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Rat dermal papilla cells have unique genes crucial for hair growth.

Dutasteride is more efficient than finasteride, but individual results vary.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.